Aju Ib Investment Co., Ltd. Portfolio Holdings

Aju Ib Investment Co., Ltd.

  • $91.6 Million
  • Q2 2025

Aju Ib Investment Co., Ltd. has filed its 13F form on July 10, 2025 for Q2 2025 where it was disclosed a total value porftolio of $91.6 Million distributed in 8 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $69M, Kymera Therapeutics, Inc. with a value of $19.9M, Seer, Inc. with a value of $1.75M, Xilio Therapeutics, Inc. with a value of $454K, and Rallybio Corp with a value of $256K.

Examining the 13F form we can see an increase of $4.23M in the current position value, from $87.4M to 91.6M.

Aju Ib Investment Co., Ltd. is based out at Seoul, M5

Below you can find more details about Aju Ib Investment Co., Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $91.6 Million
Healthcare: $91.6 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$20.1M
$454,000 0.5% of portfolio
667,742
Q4 2021 New
$14.5M
$256,000 0.28% of portfolio
754,678
Q4 2021 New
$40.2M
$124,000 0.14% of portfolio
175,000
Q4 2020 New

Summary

  • Portfolio
  • No. of Stocks 8
  • Current Value $91.6 Million
  • Prior Value $87.4 Million
  • Filing
  • Period Q2 2025
  • Filing Date July 10, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Aju Ib Investment Co., Ltd. Portfolio

Follow Aju Ib Investment Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aju Ib Investment Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Aju Ib Investment Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email